g6 Search Results


antibodies against myosin heavy chain i  (Developmental Studies Hybridoma Bank)
99
Developmental Studies Hybridoma Bank antibodies against myosin heavy chain i
Antibodies Against Myosin Heavy Chain I, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies against myosin heavy chain i/product/Developmental Studies Hybridoma Bank
Average 99 stars, based on 1 article reviews
antibodies against myosin heavy chain i - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier
glucose 6 phosphatase  (Shanghai Korain Biotech Co Ltd)
93
Shanghai Korain Biotech Co Ltd glucose 6 phosphatase
Glucose 6 Phosphatase, supplied by Shanghai Korain Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glucose 6 phosphatase/product/Shanghai Korain Biotech Co Ltd
Average 93 stars, based on 1 article reviews
glucose 6 phosphatase - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
w verdi  (Coherent Corp)
96
Coherent Corp w verdi
W Verdi, supplied by Coherent Corp, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/w verdi/product/Coherent Corp
Average 96 stars, based on 1 article reviews
w verdi - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
g6pd activity  (Elabscience Biotechnology)
93
Elabscience Biotechnology g6pd activity
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
G6pd Activity, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6pd activity/product/Elabscience Biotechnology
Average 93 stars, based on 1 article reviews
g6pd activity - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
addgene plasmid 73440  (Addgene inc)
93
Addgene inc addgene plasmid 73440
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Addgene Plasmid 73440, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/addgene plasmid 73440/product/Addgene inc
Average 93 stars, based on 1 article reviews
addgene plasmid 73440 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
koffas lab  (Addgene inc)
93
Addgene inc koffas lab
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Koffas Lab, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/koffas lab/product/Addgene inc
Average 93 stars, based on 1 article reviews
koffas lab - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
recombinant mouse gdf6  (R&D Systems)
86
R&D Systems recombinant mouse gdf6
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Recombinant Mouse Gdf6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant mouse gdf6/product/R&D Systems
Average 86 stars, based on 1 article reviews
recombinant mouse gdf6 - by Bioz Stars, 2026-04
86/100 stars
  Buy from Supplier
rhesus aavs1 cag copgfp donor plasmid  (Addgene inc)
90
Addgene inc rhesus aavs1 cag copgfp donor plasmid
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Rhesus Aavs1 Cag Copgfp Donor Plasmid, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhesus aavs1 cag copgfp donor plasmid/product/Addgene inc
Average 90 stars, based on 1 article reviews
rhesus aavs1 cag copgfp donor plasmid - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
g6pase  (Proteintech)
94
Proteintech g6pase
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
G6pase, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g6pase/product/Proteintech
Average 94 stars, based on 1 article reviews
g6pase - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
glucose 6 phosphate dehydrogenase  (Valiant Co Ltd)
93
Valiant Co Ltd glucose 6 phosphate dehydrogenase
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Glucose 6 Phosphate Dehydrogenase, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glucose 6 phosphate dehydrogenase/product/Valiant Co Ltd
Average 93 stars, based on 1 article reviews
glucose 6 phosphate dehydrogenase - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
plasmid pclic1 gfp  (OriGene)
90
OriGene plasmid pclic1 gfp
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Plasmid Pclic1 Gfp, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/plasmid pclic1 gfp/product/OriGene
Average 90 stars, based on 1 article reviews
plasmid pclic1 gfp - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
anti gastrin r  (Boster Bio)
90
Boster Bio anti gastrin r
Figure 8. The effect of MH and PI on mRNA levels of <t>g6pd</t> (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).
Anti Gastrin R, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti gastrin r/product/Boster Bio
Average 90 stars, based on 1 article reviews
anti gastrin r - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Figure 8. The effect of MH and PI on mRNA levels of g6pd (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).

Journal: International journal of molecular sciences

Article Title: Comparative Analysis of the Effects of Maternal Hypoxia and Placental Ischemia on HIF1-Dependent Metabolism and the Glucocorticoid System in the Embryonic and Newborn Rat Brain.

doi: 10.3390/ijms252413342

Figure Lengend Snippet: Figure 8. The effect of MH and PI on mRNA levels of g6pd (a) in the brain at e15, e16, e17, e20 and p1, detected by RT PCR. The effect of MH and PI on G6PD activity (b), NADPH (c), GSHred (d) and MDA (e) levels in the brain at e15, e16, e17, e20 and p1, detected by colorimetric tests. (a) mRNA levels of g6pd: e15, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e16, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test); p1, * p < 0.05 vs. control (Kruskal-Wallis, Dunn’s test); & p < 0.05 between MH and PI (Kruskal-Wallis, Dunn’s test). (b) G6PD activity: e15, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); e16, * p < 0.05 vs. control (Welch ANOVA, Dunnett’s test); e17, * p < 0.05 vs. control (one-way ANOVA, Tukey’s test), *** p < 0.001 vs. control (one-way ANOVA, Tukey’s test). (c) NADPH levels: e15, ** p < 0.01 vs. control (one-way ANOVA, Tukey’s test). (d) GSHred levels: e15: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test); & p < 0.05 between MH and PI (one-way ANOVA, Tukey’s test). e17: * p < 0.05 vs. control (one-way ANOVA, Tukey’s test).

Article Snippet: G6PD activity was analyzed using a colorimetric assay (E-BC-K056-M; Elabscience, TX, Houston, USA).

Techniques: Reverse Transcription Polymerase Chain Reaction, Activity Assay, Control